HRTX
Price
$1.21
Change
-$0.01 (-0.82%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
223.64M
40 days until earnings call
NGNE
Price
$17.81
Change
+$0.40 (+2.30%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
248.4M
Interact to see
Advertisement

HRTX vs NGNE

Header iconHRTX vs NGNE Comparison
Open Charts HRTX vs NGNEBanner chart's image
Heron Therapeutics
Price$1.21
Change-$0.01 (-0.82%)
Volume$3.82K
Capitalization223.64M
Neurogene
Price$17.81
Change+$0.40 (+2.30%)
Volume$1.91K
Capitalization248.4M
HRTX vs NGNE Comparison Chart in %
Loading...
HRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NGNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HRTX vs. NGNE commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRTX is a Hold and NGNE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (HRTX: $1.21 vs. NGNE: $17.81)
Brand notoriety: HRTX and NGNE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HRTX: 166% vs. NGNE: 51%
Market capitalization -- HRTX: $223.64M vs. NGNE: $248.4M
HRTX [@Biotechnology] is valued at $223.64M. NGNE’s [@Biotechnology] market capitalization is $248.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HRTX’s FA Score shows that 0 FA rating(s) are green whileNGNE’s FA Score has 0 green FA rating(s).

  • HRTX’s FA Score: 0 green, 5 red.
  • NGNE’s FA Score: 0 green, 5 red.
According to our system of comparison, NGNE is a better buy in the long-term than HRTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HRTX’s TA Score shows that 3 TA indicator(s) are bullish while NGNE’s TA Score has 5 bullish TA indicator(s).

  • HRTX’s TA Score: 3 bullish, 4 bearish.
  • NGNE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, NGNE is a better buy in the short-term than HRTX.

Price Growth

HRTX (@Biotechnology) experienced а -2.03% price change this week, while NGNE (@Biotechnology) price change was +3.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Reported Earning Dates

HRTX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NGNE($248M) has a higher market cap than HRTX($224M). HRTX YTD gains are higher at: -20.261 vs. NGNE (-22.091). HRTX has higher annual earnings (EBITDA): 7.54M vs. NGNE (-81.25M). NGNE has more cash in the bank: 275M vs. HRTX (40.6M). NGNE has less debt than HRTX: NGNE (12.9M) vs HRTX (177M). HRTX has higher revenues than NGNE: HRTX (150M) vs NGNE (0).
HRTXNGNEHRTX / NGNE
Capitalization224M248M90%
EBITDA7.54M-81.25M-9%
Gain YTD-20.261-22.09192%
P/E RatioN/AN/A-
Revenue150M0-
Total Cash40.6M275M15%
Total Debt177M12.9M1,372%
FUNDAMENTALS RATINGS
HRTX vs NGNE: Fundamental Ratings
HRTX
NGNE
OUTLOOK RATING
1..100
775
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
63
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
9363
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HRTX's Valuation (61) in the Biotechnology industry is in the same range as NGNE (63) in the null industry. This means that HRTX’s stock grew similarly to NGNE’s over the last 12 months.

HRTX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as NGNE (100) in the null industry. This means that HRTX’s stock grew similarly to NGNE’s over the last 12 months.

NGNE's SMR Rating (97) in the null industry is in the same range as HRTX (100) in the Biotechnology industry. This means that NGNE’s stock grew similarly to HRTX’s over the last 12 months.

NGNE's Price Growth Rating (63) in the null industry is in the same range as HRTX (93) in the Biotechnology industry. This means that NGNE’s stock grew similarly to HRTX’s over the last 12 months.

NGNE's P/E Growth Rating (100) in the null industry is in the same range as HRTX (100) in the Biotechnology industry. This means that NGNE’s stock grew similarly to HRTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HRTXNGNE
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 12 days ago
86%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
HRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NGNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BVAXD0.21N/A
+1.19%
BioVaxys Technology Corp.
KLIB140.00N/A
N/A
Killbuck Bancshares Inc.
SRBEF240.00N/A
N/A
VUSIONGROUP
CRLFF5.70-0.02
-0.35%
Cardinal Energy Ltd.
BAYRY7.91-0.16
-1.98%
Bayer A.G.

HRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRTX has been loosely correlated with CYCN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if HRTX jumps, then CYCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRTX
1D Price
Change %
HRTX100%
-2.40%
CYCN - HRTX
41%
Loosely correlated
-16.00%
VRDN - HRTX
36%
Loosely correlated
-2.15%
LGVN - HRTX
35%
Loosely correlated
-0.30%
NGNE - HRTX
34%
Loosely correlated
+0.90%
KROS - HRTX
33%
Poorly correlated
+0.32%
More

NGNE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NGNE has been loosely correlated with BRNS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if NGNE jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NGNE
1D Price
Change %
NGNE100%
+2.33%
BRNS - NGNE
50%
Loosely correlated
+0.83%
RNAZ - NGNE
48%
Loosely correlated
+2.52%
ZNTL - NGNE
47%
Loosely correlated
+5.03%
IRON - NGNE
45%
Loosely correlated
+4.88%
VRDN - NGNE
43%
Loosely correlated
+5.77%
More